Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |